One study reported that after adjusting for cholesterol level and prostate-specific antigen (PSA) screening rate, the protective effect of pre-diagnosis statins use on PC mortality disappeared, implying the healthy user effect45. The gene discussed is KLK3; the disease is pachyonychia congenita.